These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 953489)

  • 21. [Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].
    Bendix U; Bendix U
    Allerg Immunol (Leipz); 1985; 31(4):273-82. PubMed ID: 2936220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
    Williams CC; Trinh H; Tran TV; Dan Q; Sanchez R; Delgado C; Chen Y; Sippel B; Jeffes EW; Wepsic HT; Jadus MR
    Mol Ther; 2001 Feb; 3(2):216-24. PubMed ID: 11237678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of surgery on lymphocyte transformation in patients with cancer.
    Watkins SM
    Clin Exp Immunol; 1973 May; 14(1):69-76. PubMed ID: 4716104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nonspecific chemotactic response of macrophages, lymph node status and prognosis in operable cancers of the lung and breast].
    Israël L; Samak R; Grefft-Alami A; de Saint-Florent G; Battesti JP; Amouroux J
    Ann Med Interne (Paris); 1984; 135(1):26-30. PubMed ID: 6703567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression or enhancement by superoxide dismutase of tumor cell killing by macrophages of normal donors and breast cancer patients.
    Cameron DJ
    Jpn J Exp Med; 1986 Aug; 56(4):135-40. PubMed ID: 3029470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of antibody dependent cellular cytotoxic potential in macrophages obtained from normal donors and cancer patients.
    Cameron DJ
    Jpn J Exp Med; 1985 Jun; 55(3):81-7. PubMed ID: 3910883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative evaluation of the lymphocyte blast-transformation reaction induced by various mitogens in the polychemotherapy of patients with breast cancer].
    Gnatyshak AI; Sabala PI
    Eksp Onkol; 1984; 6(1):61-3. PubMed ID: 6499735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of in vivo treatment with ibuprofen on macrophage function in breast and colon cancer patients.
    Cameron DJ; O'Brien P; Majeski JA
    J Clin Lab Immunol; 1986 May; 20(1):23-8. PubMed ID: 3735395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
    Reinerová M; Veselovská Z; Ausch C; Rosen HR
    Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of lymphocytotoxicity and clinical course in human breast cancer.
    Levin AC; Schauf V; Deinhardt F; Wolter J; Massey R
    Proc Inst Med Chic; 1975; 30(6):205. PubMed ID: 1144379
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis.
    Varesio L; Holden HT
    J Immunol; 1980 Oct; 125(4):1694-701. PubMed ID: 6997385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.
    Salgame PR; Birdi TJ; Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: The immunocompetence of patients with breast cancer, as assessed by the human to mouse normal lymphocyte transfer reaction.
    Symes MO; Westwood JA; Riddell AG
    Br J Surg; 1974 Apr; 61(4):326. PubMed ID: 4832660
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune reaction to breast cancer: for better or for worse?
    Ogmundsdóttir HM
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S75-81. PubMed ID: 11665751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor-induced immunosuppression in breast cancer patients].
    Kharkevich DD; Polevaia EB; Kadagidze ZG
    Eksp Onkol; 1990; 12(5):53-6. PubMed ID: 2226260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage proliferation during a lymphocyte transformation response: a study of mouse peritoneal cells stimulated antigenically in diffusion chambers.
    Reikvam A
    J Reticuloendothel Soc; 1975 Nov; 18(5):273. PubMed ID: 1206662
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro killing of tumor cells by macrophage factors obtained from cancer patients and normal donors.
    Cameron DJ
    J Reticuloendothel Soc; 1982 Sep; 32(3):247-56. PubMed ID: 7153989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
    Kastelan M; Rudolf M; Hrsak M; Stojkovic R; Gamulin S
    Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistologic studies of macrophage infiltration and proliferation rate in breast cancer and in mastopathy].
    Vollmer E; Grundmann E; Nienhaus H; Mellin W; Zwadlo G
    Verh Dtsch Ges Pathol; 1985; 69():135-42. PubMed ID: 3913192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.